Schonfeld Strategic Advisors LLC Cerus Corp Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $372,628 - $633,359
108,638 New
108,638 $392,000
Q2 2022

Aug 15, 2022
SELL
$4.41 - $5.69 $366,471 - $472,839
-83,100 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.81 - $6.99 $399,710 - $580,869
83,100 New
83,100 $456,000
Q3 2020

Nov 16, 2020
SELL
$5.78 - $7.47 $154,349 - $199,478
-26,704 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$4.5 - $7.02 $120,168 - $187,462
26,704 New
26,704 $176,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $331M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email